Alina Salganicoff
@a_salganicoff
Followers
3K
Following
475
Statuses
3K
Senior VP @KFF & Director, Women’s Health Policy, Access to health coverage & care. RTs not endorsements.
San Francisco, CA
Joined June 2014
While Opill may open up a new path for contraceptive access, affordability and coverage will be a major consideration for consumers. KFF’s interviews with key actors show the many operational challenges that have yet to be addressed if coverage of an OTC pill is to be realized.
As Opill — the first over-the-counter daily oral contraceptive pill in the U.S. — is expected to be available for purchase in early 2024, new KFF research examines its accessibility to consumers and challenges in providing insurance coverage.
1
5
12
RT @KFF: On Friday, September 15, @KFF's @laurie_sobel and a panel of experts will explore approaches to covering over-the-counter oral con…
0
2
0
RT @KFF: Even though there is broad support for an OTC birth control pill, many likely users are price sensitive, meaning that insurance co…
0
18
0
RT @larry_levitt: Our recent survey found that 77% of reproductive-age women favor making birth control pills available over the counter, a…
0
6
0
I don't follow the Idaho legislature's rationale for disbanding their maternal mortality review panel & rejecting a Medicaid postpartum extension. Is there a plan to protect the health of those losing Medicaid or unable to get an abortion due to their ban?
0
1
7
RT @LindseyH_Dawson: Today’s SCOTUS ruling on LGBTQ rights impacts nondiscrimination protections for LGBTQ people. Our new brief provides u…
0
14
0
Great to join @jrovner for a recap of the impact of the Dobbs decision one year out. Since we recorded earlier this week, the Indiana Supreme Court upheld their abortion ban--now 15 states ban abortion.
Want a quick update on everything that's happened since SCOTUS overturned Roe v Wade? We have you covered on this week's #WTHealth podcast. W/@shefalil, @AliceOllstein, @SandhyaWrites, and @a_salganicoff:
0
1
0
RT @KFF: One year after Roe was overturned, what’s the status of federal and state developments on abortion policy? Where is abortion banne…
0
10
0
Or sign up for women's health emails @kff to get these updates and new research sent directly to your inbox
0
1
0
So pleased my @KFF colleague Usha Ranji and were able to contribute to this thoughtful collection of commentaries on what the #Dobbs decision means for many facets of women’s health.
It’s not just abortion: “there are forces at work that seek to roll back many of the changes that enable people to obtain the contraceptive method of their choice,” write @a_salganicoff & Usha Ranji. They describe ways to counter barriers & misinformation.
0
1
8
Looking forward to participating in this panel tomorrow at the #AspenIdeasHealth conference. We will have a lot of ground to cover. The impact of the #Dobbs decision overturning #RoeVsWade has been far reaching.
Tomorrow, June 22nd, our CEO @DrRaegan will be joining @errinhaines, @a_salganicoff, & @maryrziegler at #AspenIdeasHealth for an important conversation on The Fall of Roe and Its Unintended Consequences 👏 Follow along with @aspenideasto!
0
0
5
RT @KFF: In the wake of the overturning of Roe v. Wade, experts @a_salganicoff and Usha Ranji discuss the importance of addressing gaps in…
0
5
0
Many barriers to contraception are not new, but the stakes are much higher in the wake of Dobbs. Gaps in contraceptive financing, limited options and access points, and mis- and disinformation about sexual and reproductive health have compounded the impact of abortions bans.
How has the Dobbs decision affected people's ability to prevent pregnancy in the first place? @a_salganicoff & Usha Ranji of @KFF discuss post-Dobbs contraception barriers and potential solutions in a new commentary (free to read here).
0
6
12